An expert discussed fam-trastuzumab deruxtecan-nxki for HER2-mutant and -overexpressing non-small cell lung cancer.

Research is analyzing the effect of imtermittent fasting on quality of life outcomes in patients undergoing radiation therapy ...

Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ...

Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ...

Advanced practice providers discuss the second-line use of elacestrant in patients with co-mutated, ER+, HER2—advanced or ...

A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...

Early Symptom Detection and the Impact on Patient Outcomes in GVHD ...

The PDUFA dates have been pushed for sotorasib and obeticholic acid for metastatic colorectal cancer and primary biliary ...

Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.

Managing Severe Symptoms and Disease Progression in the GVHD Journey ...

Managing Severe Symptoms and Disease Progression in the GVHD Journey ...

Managing Severe Symptoms and Disease Progression in the GVHD Journey ...